- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Lantheus Holdings Faces Investigation
Kahn Swick & Foti, LLC Probes Officers and Directors of Lantheus Holdings, Inc.
Jan. 31, 2026 at 9:55pm
Got story updates? Submit your updates here. ›
Kahn Swick & Foti, LLC, a prominent securities litigation law firm, has launched an investigation into Lantheus Holdings, Inc. (NASDAQ: LNTH) and its officers and directors. The investigation follows a securities class action lawsuit filed against the company, alleging it failed to disclose material information about its flagship product Pylarify's pricing and reimbursement risks.
Why it matters
The investigation by Kahn Swick & Foti could lead to further legal action against Lantheus Holdings and its leadership, potentially impacting the company's financial standing and reputation. As a major player in the medical imaging industry, any findings of wrongdoing or breach of fiduciary duties could have broader implications for the sector.
The details
In August 2025, Lantheus Holdings disclosed an 8% year-over-year decline in Pylarify revenue and cuts to its full-year guidance, citing widespread contract renegotiations and account losses. This contradicted the company's prior optimistic outlook for Pylarify's growth potential. The subsequent securities class action lawsuit alleges that Lantheus and its executives failed to disclose material information about the pricing and reimbursement risks created by a Centers for Medicare & Medicaid Services rule shift.
- In August 2025, Lantheus Holdings disclosed an 8% year-over-year decline in Pylarify revenue and cuts to its full-year guidance.
- The securities class action lawsuit against Lantheus Holdings was filed after the company's August 2025 disclosures.
The players
Lantheus Holdings, Inc.
A medical imaging company that develops and commercializes diagnostic and therapeutic products, including its flagship product Pylarify.
Kahn Swick & Foti, LLC
A prominent securities litigation law firm that has commenced an investigation into Lantheus Holdings and its officers and directors.
Charles C. Foti, Jr.
A partner at Kahn Swick & Foti, LLC and former Attorney General of Louisiana, who is leading the investigation into Lantheus Holdings.
What they’re saying
“KSF's investigation is focusing on whether Lantheus' officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.”
— Charles C. Foti, Jr., Partner, Kahn Swick & Foti, LLC (BusinessWire)
What’s next
The ongoing securities class action lawsuit against Lantheus Holdings and its executives will likely be a key focus of the investigation by Kahn Swick & Foti.
The takeaway
The investigation by Kahn Swick & Foti into Lantheus Holdings highlights the potential legal and reputational risks facing the company and its leadership. The outcome of this probe could have significant implications for the medical imaging industry and serve as a cautionary tale about the importance of transparent and responsible corporate governance.
New Orleans top stories
New Orleans events
Mar. 18, 2026
Delfeayo Marsalis & the Uptown Jazz OrchestraMar. 18, 2026
Delfeayo Marsalis & the Uptown Jazz Orchestra




